Whale Analyzer
Top public holders · 13F and disclosure aggregation

Who owns DHR? 13F holders and whale ownership

DHR is tracked across public portfolios in Whale Analyzer. This page answers who owns DHR, which top funds are buying DHR, aggregate disclosed value, and recent position changes based on public data. Capital Group is the largest reported holder at $1.69B; the top five funds control 92.3% of reported ownership; institutions were net selling last quarter (4 increased, 4 reduced); the stock trades above the aggregate whale cost basis of $173.46. Top tracked holders include Capital Group, Al Gore / David Blood, Dan Sundheim, and PRIMECAP Management.

Continue to the live DHR dashboard
NYQ · latest quote
$196.19
+$19.02 (+10.7%)
Open live DHR dashboard
10Tracked holders
$4.29BAggregate reported value
2026-05-21Page updated
4 reduced, 3 increased, 2 held, 1 newRecent changes

Top holders

InvestorReported valueSharesChange
Capital Group 13F portfolio
Capital Research Global Investors holdings
$1.69B8.9MIncreased
Al Gore / David Blood 13F portfolio
Generation Investment Management holdings
$1.38B7.3MReduced
Dan Sundheim 13F portfolio
D1 Capital Partners holdings
$436.9M2.3MIncreased
PRIMECAP Management 13F portfolio
PRIMECAP Management Company holdings
$295.2M1.6MIncreased
Lee Ainslie 13F portfolio
Maverick Capital holdings
$155.4M819.7KNew
Dorsey Asset Management 13F portfolio
Dorsey Asset Management holdings
$110.0M580.2KReduced
Dan Loeb 13F portfolio
Third Point holdings
$99.5M525.0KReduced
Bill Gates 13F portfolio
Bill & Melinda Gates Foundation holdings
$70.7M373.0KHeld
Samuel Isaly 13F portfolio
OrbiMed Advisors holdings
$50.4M265.8KReduced
Edgewood Management 13F portfolio
Edgewood Management LLC holdings
$1.3M6.8KHeld

Ownership concentration

Reported ownership of DHR is highly concentrated across tracked institutions.

Whale activity this quarter

Across 10 tracked institutions, 4 increased, 4 reduced, 2 held. Net positioning is net selling.

Whale cost basis vs current price

The aggregate tracked cost basis is $173.46 versus a current price of $196.19, so DHR trades above its cost basis (+13.1%). Average unrealized P&L across tracked holders: 154%.

Sector positioning — Health Care

DHR sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:

How to use this page

Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live DHR dashboard for price charts and cross-investor scans, or read the SEC 13F guide.

This page is generated from public filings and public disclosures. It is for research and education only and is not investment advice.

Related stock holder pages

Learn more in Whale Analyzer Academy

Deepen your read on DHR with these Whale Analyzer Academy guides:

Frequently asked questions

Who owns DHR stock?

Whale Analyzer tracks 10 public institutional holders of DHR with a combined reported value of $4.29B. See the holder table above for the largest tracked positions.

Which top funds are buying DHR?

Tracked institutions were net selling last quarter — 4 increased, 4 reduced, 2 held. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.

How concentrated is DHR ownership?

The top five tracked holders report 92.3% of aggregate ownership.

Is DHR above or below the whale cost basis?

The aggregate tracked cost basis is $173.46 versus a current price of $196.19 (+13.1%).

What does 13F ownership mean for DHR?

Use the interactive DHR dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.